A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
Clinical trial NCT06971523 · RECRUITING
Trial details
- NCT number
- NCT06971523
- Sponsor
- CytosinLab Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-25
- Primary completion
- 2028-12-31
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.